Drug Approval | January 28, 2022
European Commission approves Merck’s KEYTRUDA as adjuvant therapy for RCC
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
KEYTRUDA is now approved as monotherapy for adults with Renal Cell Carcinoma (RCC)
New capabilities on Philips Image Guided therapy mobile C-arm system – Zenition – and collaboration with Cydar offer the latest advances in endovascular treatment
_256_384.jpg)
Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve
Occupancy is expected to be in the range of 60-62% while Average Revenue Per Occupied Bed (ARPOB) is expected to expand by least 6% in FY2022
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022
The hospital has recently launched Radionuclide therapy
Subscribe To Our Newsletter & Stay Updated
